Each dot is one of the 71 Medical Devices stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 9.5% and the median P/E 30.88. Pinned to the edge: 7 outliers on X and 2 on Y.
Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.
| # | Industry | ||||
|---|---|---|---|---|---|
| 1 | JNJJohnson & Johnson | 7.8% | 42.83 | $688.76B | Pharmaceuticals |
| 2 | ABTAbbott Laboratories | 10.0% | 40.05 | $187.98B | Medical Devices |
| 3 | ISRGIntuitive Surgical | 20.5% | 52.35 | $153.75B | Medical Devices |
| 4 | MDTMedtronic | 12.8% | 15.04 | $131.67B | Medical Devices |
| 5 | SYKStryker | 7.9% | 32.65 | $117.84B | Medical Devices |
| 6 | BSXBoston Scientific | 8.9% | 18.34 | $64.27B | Medical Devices |
| 7 | TELTE Connectivity | 15.2% | 19.41 | $62.00B | Electrical Equipment |
| 8 | EWEdwards Lifesciences | 13.4% | 60.87 | $61.69B | Medical Devices |
| 9 | AMEAmetek | 14.3% | 34.00 | $55.50B | Industrial Machinery |
| 10 | GEHCGE HealthCare Technologies | 6.9% | 17.42 | $37.54B | Diagnostic Equipment |
| 11 | ALCAlcon | 8.0% | 54.90 | $36.13B | Medical Devices |
| 12 | RMDResmed | 9.0% | 21.50 | $33.69B | Medical Devices |
| 13 | DXCMDexcom | 13.0% | 31.51 | $31.08B | Medical Devices |
| 14 | PHGKoninklijke Philips | 53.4%OUT | 15.11 | $29.22B | Diagnostic Equipment |
| 15 | WSTWest Pharmaceutical Services | 12.6% | 45.92 | $29.09B | Medical Supplies |
| 16 | STESteris | 8.1% | 31.11 | $25.67B | Medical Devices |
| 17 | FTVFortive | 7.0% | 31.31 | $20.25B | Industrial Machinery |
| 18 | ZBHZimmer Biomet Holdings | 7.0% | 25.63 | $19.53B | Medical Devices |
| 19 | NDSNNordson | 7.0% | 32.59 | $18.09B | Industrial Machinery |
| 20 | IEXIdex | 6.9% | 32.69 | $17.45B | Pumps and Valves |
| 21 | SOLVSolventum | -2.8% | 97.50 | $15.13B | Medical Devices |
| 22 | PENPenumbra | 17.0% | 80.51 | $12.65B | Medical Devices |
| 23 | COOCooper Companies | 4.7% | 21.20 | $11.91B | Medical Devices |
| 24 | HALOHalozyme Therapeutics | 45.0%OUT | 23.51 | $11.42B | Biotechnology |
| 25 | PODDInsulet | 26.5% | 24.66 | $10.58B | Medical Devices |
| 26 | MOG-AMoog | 15.7% | 28.54 | $9.66B | Defense |
| 27 | GMEDGlobus Medical | 13.4% | 17.35 | $9.56B | Medical Devices |
| 28 | HNGEHinge Health | 49.9%OUT | 56.01 | $9.37B | Telehealth |
| 29 | ATRAptargroup | 9.0% | 33.99 | $9.06B | Industrial Machinery |
| 30 | FMSFresenius Medical Care AG | -49.1%OUT | 6.71 | $6.16B | Healthcare Services |
| 31 | TFXTeleflex | 20.9% | 21.11 | $6.15B | Medical Devices |
| 32 | HAEHaemonetics | 4.1% | 53.80 | $5.59B | Medical Devices |
| 33 | MMSIMerit Medical Systems | 9.1% | 32.36 | $5.19B | Medical Devices |
| 34 | LIVNLivaNova | 11.7% | 25.66 | $5.03B | Medical Devices |
| 35 | STVNStevanato Group S.p.A | 12.0% | 26.46 | $4.78B | Medical Supplies |
| 36 | NOVTNovanta | 13.2% | 95.30 | $4.50B | Industrial Machinery |
| 37 | ICUIIcu Medical | -5.9% | 74.31 | $4.48B | Medical Devices |
| 38 | ITGRInteger Holdings | -0.3% | 41.57 | $4.31B | Medical Devices |
| 39 | TMDXTransMedics | 28.5% | 21.94 | $3.17B | Medical Devices |
| 40 | VCELVericel | 25.3% | 87.53 | $2.91B | Gene and Cell Therapy |
| 41 | ATRCAtriCure | 13.8% | 186.73OUT | $2.89B | Medical Devices |
| 42 | IPGPIpg Photonics | 14.8% | 71.41 | $2.88B | Industrial Machinery |
| 43 | UFPTUfp Technologies | 8.6% | 30.88 | $2.36B | Medical Devices |
| 44 | LMATLemaitre Vascular | 11.8% | 28.27 | $1.79B | Medical Devices |
| 45 | INSPInspire Medical Systems | -0.2% | 17.57 | $1.77B | Medical Devices |
| 46 | OMCLOmnicell | 5.6% | 35.99 | $1.61B | Medical Devices |
| 47 | CNMDConmed | 1.6% | 20.59 | $1.51B | Medical Devices |
| 48 | PCRXPacira BioSciences | 3.7% | 38.52 | $1.45B | Pharmaceuticals |
| 49 | STAAStaar Surgical | 42.4% | 2,517OUT | $1.32B | Medical Devices |
| 50 | IARTIntegra Lifesciences Holdings | 0.8% | 85.64 | $1.12B | Medical Devices |
| 51 | IRMDIradimed | 11.0% | 45.50 | $1.09B | Medical Devices |
| 52 | BVSBioventus | 3.9% | 12.72 | $898.22M | Medical Devices |
| 53 | THRMGentherm | 8.8% | 98.72 | $893.07M | Industrial Machinery |
| 54 | INMDInMode | 2.5% | 11.51 | $840.77M | Medical Devices |
| 55 | DCTHDelcath Systems | 38.1% | 111.41 | $714.55M | Medical Devices |
| 56 | TCMDTactile Systems Technology | 14.4% | 25.48 | $603.12M | Medical Devices |
| 57 | BWAYBrainsway | 33.1% | 37.84 | $395.97M | Medical Devices |
| 58 | MTLSMaterialise | 9.5% | 25.88 | $383.35M | Business Process Automation |
| 59 | EMBCEmbecta | -7.6% | 4.32 | $366.02M | Medical Devices |
| 60 | PROFProfound Medical | 65.3%OUT | 5.15 | $271.77M | Medical Devices |
| 61 | UTMDUtah Medical Products | -9.6% | 22.09 | $228.50M | Medical Devices |
| 62 | PDEXPro Dex | 13.3% | 17.50 | $210.33M | Medical Devices |
| 63 | ELMDElectromed | 14.1% | 16.94 | $200.31M | Medical Devices |
| 64 | HSDTSolana | 1,466%OUT | 0.46 | $147.09M | Crypto Exchanges |
| 65 | VATEInnovate | 51.3%OUT | 51.28 | $63.06M | Engineering and Construction |
| 66 | LNSRLensar | 1.6% | 3.81 | $61.47M | Medical Devices |
| 67 | MDNCMedinotec | -10.9% | 98.45 | $58.78M | Medical Devices |
| 68 | VASOVaso | 3.4% | 19.73 | $49.29M | Medical Devices |
| 69 | NEPHNephros | 20.4% | 17.34 | $33.15M | Medical Devices |
| 70 | SNWVSANUWAVE Health | 0.8% | 3.77 | $15.66M | Medical Devices |
| 71 | ESMCEscalon Medical | 5.7% | 0.67 | $1.26M | Medical Devices |
Among Medical Devices stocks, the largest companies growing revenue faster than the median (9.5%) while trading below the median P/E (30.88) are Medtronic (MDT), TE Connectivity (TEL), Koninklijke Philips (PHG), Halozyme Therapeutics (HALO) and Insulet (PODD). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.
The largest companies with a P/E above the median and revenue growth below it are Johnson & Johnson (JNJ), Stryker (SYK), Alcon (ALC), Steris (STE) and Fortive (FTV).
The median P/E across the 71 Medical Devices stocks plotted is 30.88, with the middle half between 18.88 and 48.60.
The median is 9.5%, with the middle half between 5.2% and 15.0%.
The rank correlation (Spearman) is 0.10, a weak positive relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a higher P/E.
A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 7 companies are outliers on Revenue Growth (1y) (TTM) and 2 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.
Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.